News – Page 346 – Endpoints News

On a personal mission for his daughter, Paul Bresge launches another eye disease biotech with $100M for Ray ...

3 years ago

$97M gene therapy consortium aims to give companies and rare disease families a ‘north star’

3 years ago

Peter Hecht has a new syndicate, $81M in backing and a fresh shot at glory as his last start-up sputters out

3 years ago

Astellas, Sony partner up for antibody-drug conjugate platform to create 'better performing' drugs

3 years ago

FTC sues to block $28B Amgen-Horizon deal, in move that will send shockwaves through biopharma M&A

3 years ago

Families raised millions and handed rare disease therapies off to biotechs. But companies have backed out

3 years ago

Dermavant's Vtama works again in eczema as Roivant subsidiary seeks label expansion next year

3 years ago

Boundless Bio snags $100M to enter clinic and fight cancer by targeting circular DNA bits

3 years ago

Metaphore Biotechnologies seeks to mimic nature with $50M for autoimmune, immunology drugs out of Flagship

3 years ago

Bayer cuts four programs amid a 'slow start' to the year

3 years ago

Talc claimants look to sue J&J over alleged fraud in bankruptcy case

3 years ago

Colombian man's genetics should have doomed him to Alzheimer's. Instead, a rare mutation offers clue to protection

3 years ago

Moderna goes after Alnylam, filing counterclaims in Spikevax patent suit

3 years ago

New Alzheimer's drugs from Eisai and Lilly: Expectations set at $10B+ in combined sales by 2030

3 years ago

AstraZeneca changes up asthma campaign, moves to highlight control for hard-to-control subtype

3 years ago

Gilead expands its big bet on Arcus, moving into inflammation in large new collaboration

3 years ago

UniQure sells part of Hemgenix royalty for $400M cash

3 years ago

FDA issues CRL to small Dutch biotech's breast cancer ADC as OS figures fail to impress

3 years ago

Still under clinical hold, Fulcrum locks in seasoned commercial leader as CEO

3 years ago

Verve names second PCSK9 candidate; Exscientia picks another AI-created molecule for clinic

3 years ago

President Biden nominates NCI director Monica Bertagnolli to lead NIH

3 years ago

Belgian biotech Dualyx enters Treg field with $44M for 2024 clinical entry

3 years ago

SCOTUS declines to take up 'skinny' label generic drug case, raising questions about future carve outs

3 years ago

Athenex files for bankruptcy to pave way for firesale of programs, ending 20-year run

3 years ago

First page Previous page 343 344 345346347 348 349 Next page Last page